• CGRP in migraine: current therapeutics, future implications and potential off-target effects

  • Dec 21 2021
  • Length: 10 mins
  • Podcast

CGRP in migraine: current therapeutics, future implications and potential off-target effects

  • Summary

  • In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the growing body of evidence for the role of therapies directed against this protein in migraine and beyond. He also highlights emerging off-target side effects to monitor for.

    Related article: https://jnnp.bmj.com/content/92/12/1325

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about CGRP in migraine: current therapeutics, future implications and potential off-target effects

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.